Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? by Zuzaan Zulzaga, Erdenetuya Myagmarsuren, Herman J. Woerdenbag, Eugene P. van Puijenbroek

Get full text

Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review by Tanja Fens, Pieter T. de Boer, Eugène P. van Puijenbroek, Maarten J. Postma

Get full text

Electronic Health Record–Triggered Research Infrastructure Combining Real-world Electronic Health Record Data and Patient-Reported Outcomes to Detect Benefits, Risks, and Impact of... by Karin Hek, Leàn Rolfes, Eugène P van Puijenbroek, Linda E Flinterman, Saskia Vorstenbosch, Liset van Dijk, Robert A Verheij

Get full text

Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis by Barbara J. M. Bergmans, Biniyam Y. Gebeyehu, Eugène P. van Puijenbroek, Katrijn Van Deun, Bennett Kleinberg, Jean-Luc Murk, Esther de Vries

Get full text

Elements to assess the quality of information of case reports in pregnancy pharmacovigilance data—a ConcePTION project by Yrea R. J. van Rijt-Weetink, Yrea R. J. van Rijt-Weetink, Khoezik Chamani, Antoine C. G. Egberts, Antoine C. G. Egberts, Florence P. A. M. van Hunsel, Florence P. A. M. van Hunsel, David J. Lewis, David J. Lewis, Laura M. Yates, Laura M. Yates, Ursula Winterfeld, Eugène P. van Puijenbroek, Eugène P. van Puijenbroek

Get full text

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care by Anne T. M. Dittrich, Nori J. L. Smeets, Emma F. M. de Jong, Juliët L. Kämink, Yvet Kroeze, Jos M. Th. Draaisma, Eugène P. van Puijenbroek, D. Maroeska W. M. te Loo

Get full text